INFOGRAPHIC: ENVISION study
Long-term clinical outcomes of patients with acute hepatic porphyria who were not attack-free after 6 months of givosiran treatment: a subgroup analysis of the phase 3 ENVISION study
Click the 'plus' icon on each tile to view the content.
Introduction
What is givosiran?
A medicine that is used to treat adults with AHP that prevents the build-up of ALA and PBG in the body